ID: ALA2403179

Max Phase: Preclinical

Molecular Formula: C44H38I4N8

Molecular Weight: 678.84

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[n+]1ccc(-c2c3nc(c(-c4cc[n+](C)cc4)c4ccc([nH]4)c(-c4cc[n+](C)cc4)c4nc(c(-c5cc[n+](C)cc5)c5ccc2[nH]5)C=C4)C=C3)cc1.[I-].[I-].[I-].[I-]

Standard InChI:  InChI=1S/C44H37N8.4HI/c1-49-21-13-29(14-22-49)41-33-5-7-35(45-33)42(30-15-23-50(2)24-16-30)37-9-11-39(47-37)44(32-19-27-52(4)28-20-32)40-12-10-38(48-40)43(36-8-6-34(41)46-36)31-17-25-51(3)26-18-31;;;;/h5-28H,1-4H3,(H,45,46,47,48);4*1H/q+3;;;;/p-3/b41-33-,41-34-,42-35-,42-37-,43-36-,43-38-,44-39-,44-40-;;;;

Standard InChI Key:  IWUSKFYHLANXSV-GVHKZQBISA-K

Associated Targets(non-human)

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus warneri 476 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pseudomonas aeruginosa 123386 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Enterococcus faecalis 29875 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 678.84Molecular Weight (Monoisotopic): 678.3197AlogP: 6.62#Rotatable Bonds: 4
Polar Surface Area: 72.88Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.66CX LogP: -9.42CX LogD: -9.42
Aromatic Rings: 7Heavy Atoms: 52QED Weighted: 0.21Np Likeness Score: 0.07

References

1. Alves E, Faustino MA, Tomé JP, Neves MG, Tomé AC, Cavaleiro JA, Cunha A, Gomes NC, Almeida A..  (2013)  Nucleic acid changes during photodynamic inactivation of bacteria by cationic porphyrins.,  21  (14): [PMID:23719285] [10.1016/j.bmc.2013.04.065]
2. Slomp AM, Barreira SMW, Carrenho LZB, Vandresen CC, Zattoni IF, Ló SMS, Dallagnol JCC, Ducatti DRB, Orsato A, Duarte MER, Noseda MD, Otuki MF, Gonçalves AG..  (2017)  Photodynamic effect of meso-(aryl)porphyrins and meso-(1-methyl-4-pyridinium)porphyrins on HaCaT keratinocytes.,  27  (2): [PMID:27956348] [10.1016/j.bmcl.2016.11.094]
3. Le Guern F, Ouk TS, Ouk C, Vanderesse R, Champavier Y, Pinault E, Sol V..  (2018)  Lysine Analogue of Polymyxin B as a Significant Opportunity for Photodynamic Antimicrobial Chemotherapy.,  (1): [PMID:29348804] [10.1021/acsmedchemlett.7b00360]
4. Sobotta L, Skupin-Mrugalska P, Piskorz J, Mielcarek J..  (2019)  Porphyrinoid photosensitizers mediated photodynamic inactivation against bacteria.,  175  [PMID:31096157] [10.1016/j.ejmech.2019.04.057]
5. Janas K, Boniewska-Bernacka E, Dyrda G, Słota R..  (2021)  Porphyrin and phthalocyanine photosensitizers designed for targeted photodynamic therapy of colorectal cancer.,  30  [PMID:33341498] [10.1016/j.bmc.2020.115926]

Source